Global Antithrombin Market Insights and Forecast to 2028

Publisher Name :
Date: 25-Feb-2022
No. of pages: 93
Inquire Before Buying

Antithrombin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antithrombin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Liquid

- Lyophilized

Segment by Application

- Diagnostics

- Therapeutics

- Research

By Company

- Grifols

- rEVO Biologics Inc.

- Takeda

- Kedrion S.p.A.

- CSL Limited

- Scripps Laboratories Inc.

- Lee Biosolutions

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Antithrombin Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Antithrombin Product Introduction
1.2 Market by Type
1.2.1 Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market by Application
1.3.1 Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antithrombin Sales Estimates and Forecasts 2017-2028
2.2 Global Antithrombin Revenue Estimates and Forecasts 2017-2028
2.3 Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antithrombin Sales by Region
2.4.1 Global Antithrombin Sales by Region (2017-2022)
2.4.2 Global Sales Antithrombin by Region (2023-2028)
2.5 Global Antithrombin Revenue by Region
2.5.1 Global Antithrombin Revenue by Region (2017-2022)
2.5.2 Global Antithrombin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antithrombin Sales by Manufacturers
3.1.1 Global Top Antithrombin Manufacturers by Sales (2017-2022)
3.1.2 Global Antithrombin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antithrombin in 2021
3.2 Global Antithrombin Revenue by Manufacturers
3.2.1 Global Antithrombin Revenue by Manufacturers (2017-2022)
3.2.2 Global Antithrombin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antithrombin Revenue in 2021
3.3 Global Antithrombin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antithrombin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antithrombin Sales by Type
4.1.1 Global Antithrombin Historical Sales by Type (2017-2022)
4.1.2 Global Antithrombin Forecasted Sales by Type (2023-2028)
4.1.3 Global Antithrombin Sales Market Share by Type (2017-2028)
4.2 Global Antithrombin Revenue by Type
4.2.1 Global Antithrombin Historical Revenue by Type (2017-2022)
4.2.2 Global Antithrombin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antithrombin Revenue Market Share by Type (2017-2028)
4.3 Global Antithrombin Price by Type
4.3.1 Global Antithrombin Price by Type (2017-2022)
4.3.2 Global Antithrombin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antithrombin Sales by Application
5.1.1 Global Antithrombin Historical Sales by Application (2017-2022)
5.1.2 Global Antithrombin Forecasted Sales by Application (2023-2028)
5.1.3 Global Antithrombin Sales Market Share by Application (2017-2028)
5.2 Global Antithrombin Revenue by Application
5.2.1 Global Antithrombin Historical Revenue by Application (2017-2022)
5.2.2 Global Antithrombin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antithrombin Revenue Market Share by Application (2017-2028)
5.3 Global Antithrombin Price by Application
5.3.1 Global Antithrombin Price by Application (2017-2022)
5.3.2 Global Antithrombin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antithrombin Market Size by Type
6.1.1 North America Antithrombin Sales by Type (2017-2028)
6.1.2 North America Antithrombin Revenue by Type (2017-2028)
6.2 North America Antithrombin Market Size by Application
6.2.1 North America Antithrombin Sales by Application (2017-2028)
6.2.2 North America Antithrombin Revenue by Application (2017-2028)
6.3 North America Antithrombin Market Size by Country
6.3.1 North America Antithrombin Sales by Country (2017-2028)
6.3.2 North America Antithrombin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antithrombin Market Size by Type
7.1.1 Europe Antithrombin Sales by Type (2017-2028)
7.1.2 Europe Antithrombin Revenue by Type (2017-2028)
7.2 Europe Antithrombin Market Size by Application
7.2.1 Europe Antithrombin Sales by Application (2017-2028)
7.2.2 Europe Antithrombin Revenue by Application (2017-2028)
7.3 Europe Antithrombin Market Size by Country
7.3.1 Europe Antithrombin Sales by Country (2017-2028)
7.3.2 Europe Antithrombin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antithrombin Market Size by Type
8.1.1 Asia Pacific Antithrombin Sales by Type (2017-2028)
8.1.2 Asia Pacific Antithrombin Revenue by Type (2017-2028)
8.2 Asia Pacific Antithrombin Market Size by Application
8.2.1 Asia Pacific Antithrombin Sales by Application (2017-2028)
8.2.2 Asia Pacific Antithrombin Revenue by Application (2017-2028)
8.3 Asia Pacific Antithrombin Market Size by Region
8.3.1 Asia Pacific Antithrombin Sales by Region (2017-2028)
8.3.2 Asia Pacific Antithrombin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antithrombin Market Size by Type
9.1.1 Latin America Antithrombin Sales by Type (2017-2028)
9.1.2 Latin America Antithrombin Revenue by Type (2017-2028)
9.2 Latin America Antithrombin Market Size by Application
9.2.1 Latin America Antithrombin Sales by Application (2017-2028)
9.2.2 Latin America Antithrombin Revenue by Application (2017-2028)
9.3 Latin America Antithrombin Market Size by Country
9.3.1 Latin America Antithrombin Sales by Country (2017-2028)
9.3.2 Latin America Antithrombin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antithrombin Market Size by Type
10.1.1 Middle East and Africa Antithrombin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antithrombin Revenue by Type (2017-2028)
10.2 Middle East and Africa Antithrombin Market Size by Application
10.2.1 Middle East and Africa Antithrombin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antithrombin Revenue by Application (2017-2028)
10.3 Middle East and Africa Antithrombin Market Size by Country
10.3.1 Middle East and Africa Antithrombin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antithrombin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Overview
11.1.3 Grifols Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Grifols Recent Developments
11.2 rEVO Biologics Inc.
11.2.1 rEVO Biologics Inc. Corporation Information
11.2.2 rEVO Biologics Inc. Overview
11.2.3 rEVO Biologics Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 rEVO Biologics Inc. Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Recent Developments
11.4 Kedrion S.p.A.
11.4.1 Kedrion S.p.A. Corporation Information
11.4.2 Kedrion S.p.A. Overview
11.4.3 Kedrion S.p.A. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion S.p.A. Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Scripps Laboratories Inc.
11.6.1 Scripps Laboratories Inc. Corporation Information
11.6.2 Scripps Laboratories Inc. Overview
11.6.3 Scripps Laboratories Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Scripps Laboratories Inc. Recent Developments
11.7 Lee Biosolutions
11.7.1 Lee Biosolutions Corporation Information
11.7.2 Lee Biosolutions Overview
11.7.3 Lee Biosolutions Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lee Biosolutions Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antithrombin Industry Chain Analysis
12.2 Antithrombin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antithrombin Production Mode & Process
12.4 Antithrombin Sales and Marketing
12.4.1 Antithrombin Sales Channels
12.4.2 Antithrombin Distributors
12.5 Antithrombin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antithrombin Industry Trends
13.2 Antithrombin Market Drivers
13.3 Antithrombin Market Challenges
13.4 Antithrombin Market Restraints
14 Key Findings in The Global Antithrombin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Liquid
Table 3. Major Manufacturers of Lyophilized
Table 4. Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Antithrombin Sales by Region (2017-2022) & (Units)
Table 7. Global Antithrombin Sales Market Share by Region (2017-2022)
Table 8. Global Antithrombin Sales by Region (2023-2028) & (Units)
Table 9. Global Antithrombin Sales Market Share by Region (2023-2028)
Table 10. Global Antithrombin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Antithrombin Revenue Market Share by Region (2017-2022)
Table 12. Global Antithrombin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Antithrombin Revenue Market Share by Region (2023-2028)
Table 14. Global Antithrombin Sales by Manufacturers (2017-2022) & (Units)
Table 15. Global Antithrombin Sales Share by Manufacturers (2017-2022)
Table 16. Global Antithrombin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Antithrombin Revenue Share by Manufacturers (2017-2022)
Table 18. Antithrombin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Antithrombin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Antithrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2021)
Table 21. Antithrombin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antithrombin Product Offered
Table 23. Date of Manufacturers Enter into Antithrombin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antithrombin Sales by Type (2017-2022) & (Units)
Table 26. Global Antithrombin Sales by Type (2023-2028) & (Units)
Table 27. Global Antithrombin Sales Share by Type (2017-2022)
Table 28. Global Antithrombin Sales Share by Type (2023-2028)
Table 29. Global Antithrombin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Antithrombin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Antithrombin Revenue Share by Type (2017-2022)
Table 32. Global Antithrombin Revenue Share by Type (2023-2028)
Table 33. Antithrombin Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Antithrombin Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Antithrombin Sales by Application (2017-2022) & (Units)
Table 36. Global Antithrombin Sales by Application (2023-2028) & (Units)
Table 37. Global Antithrombin Sales Share by Application (2017-2022)
Table 38. Global Antithrombin Sales Share by Application (2023-2028)
Table 39. Global Antithrombin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Antithrombin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Antithrombin Revenue Share by Application (2017-2022)
Table 42. Global Antithrombin Revenue Share by Application (2023-2028)
Table 43. Antithrombin Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Antithrombin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Antithrombin Sales by Type (2017-2022) & (Units)
Table 46. North America Antithrombin Sales by Type (2023-2028) & (Units)
Table 47. North America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Antithrombin Sales by Application (2017-2022) & (Units)
Table 50. North America Antithrombin Sales by Application (2023-2028) & (Units)
Table 51. North America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Antithrombin Sales by Country (2017-2022) & (Units)
Table 54. North America Antithrombin Sales by Country (2023-2028) & (Units)
Table 55. North America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Antithrombin Sales by Type (2017-2022) & (Units)
Table 58. Europe Antithrombin Sales by Type (2023-2028) & (Units)
Table 59. Europe Antithrombin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Antithrombin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Antithrombin Sales by Application (2017-2022) & (Units)
Table 62. Europe Antithrombin Sales by Application (2023-2028) & (Units)
Table 63. Europe Antithrombin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Antithrombin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Antithrombin Sales by Country (2017-2022) & (Units)
Table 66. Europe Antithrombin Sales by Country (2023-2028) & (Units)
Table 67. Europe Antithrombin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Antithrombin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Antithrombin Sales by Type (2017-2022) & (Units)
Table 70. Asia Pacific Antithrombin Sales by Type (2023-2028) & (Units)
Table 71. Asia Pacific Antithrombin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Antithrombin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Antithrombin Sales by Application (2017-2022) & (Units)
Table 74. Asia Pacific Antithrombin Sales by Application (2023-2028) & (Units)
Table 75. Asia Pacific Antithrombin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Antithrombin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Antithrombin Sales by Region (2017-2022) & (Units)
Table 78. Asia Pacific Antithrombin Sales by Region (2023-2028) & (Units)
Table 79. Asia Pacific Antithrombin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Antithrombin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Antithrombin Sales by Type (2017-2022) & (Units)
Table 82. Latin America Antithrombin Sales by Type (2023-2028) & (Units)
Table 83. Latin America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Antithrombin Sales by Application (2017-2022) & (Units)
Table 86. Latin America Antithrombin Sales by Application (2023-2028) & (Units)
Table 87. Latin America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Antithrombin Sales by Country (2017-2022) & (Units)
Table 90. Latin America Antithrombin Sales by Country (2023-2028) & (Units)
Table 91. Latin America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Antithrombin Sales by Type (2017-2022) & (Units)
Table 94. Middle East and Africa Antithrombin Sales by Type (2023-2028) & (Units)
Table 95. Middle East and Africa Antithrombin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Antithrombin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Antithrombin Sales by Application (2017-2022) & (Units)
Table 98. Middle East and Africa Antithrombin Sales by Application (2023-2028) & (Units)
Table 99. Middle East and Africa Antithrombin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Antithrombin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Antithrombin Sales by Country (2017-2022) & (Units)
Table 102. Middle East and Africa Antithrombin Sales by Country (2023-2028) & (Units)
Table 103. Middle East and Africa Antithrombin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Antithrombin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Grifols Corporation Information
Table 106. Grifols Description and Major Businesses
Table 107. Grifols Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Grifols Recent Developments
Table 110. rEVO Biologics Inc. Corporation Information
Table 111. rEVO Biologics Inc. Description and Major Businesses
Table 112. rEVO Biologics Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. rEVO Biologics Inc. Recent Developments
Table 115. Takeda Corporation Information
Table 116. Takeda Description and Major Businesses
Table 117. Takeda Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Takeda Recent Developments
Table 120. Kedrion S.p.A. Corporation Information
Table 121. Kedrion S.p.A. Description and Major Businesses
Table 122. Kedrion S.p.A. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Kedrion S.p.A. Recent Developments
Table 125. CSL Limited Corporation Information
Table 126. CSL Limited Description and Major Businesses
Table 127. CSL Limited Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CSL Limited Recent Developments
Table 130. Scripps Laboratories Inc. Corporation Information
Table 131. Scripps Laboratories Inc. Description and Major Businesses
Table 132. Scripps Laboratories Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Scripps Laboratories Inc. Recent Developments
Table 135. Lee Biosolutions Corporation Information
Table 136. Lee Biosolutions Description and Major Businesses
Table 137. Lee Biosolutions Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Lee Biosolutions Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Antithrombin Distributors List
Table 143. Antithrombin Customers List
Table 144. Antithrombin Market Trends
Table 145. Antithrombin Market Drivers
Table 146. Antithrombin Market Challenges
Table 147. Antithrombin Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Antithrombin Product Picture
Figure 3. Global Antithrombin Market Share by Type in 2021 & 2028
Figure 3. Liquid Product Picture
Figure 4. Lyophilized Product Picture
Figure 5. Global Antithrombin Market Share by Application in 2021 & 2028
Figure 6. Diagnostics
Figure 7. Therapeutics
Figure 8. Research
Figure 9. Antithrombin Report Years Considered
Figure 10. Global Antithrombin Sales 2017-2028 (Units)
Figure 11. Global Antithrombin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Antithrombin Revenue 2017-2028 (US$ Million)
Figure 13. Global Antithrombin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Antithrombin Sales Market Share by Region (2017-2022)
Figure 15. Global Antithrombin Sales Market Share by Region (2023-2028)
Figure 16. North America Antithrombin Sales YoY (2017-2028) & (Units)
Figure 17. North America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Antithrombin Sales YoY (2017-2028) & (Units)
Figure 19. Europe Antithrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Antithrombin Sales YoY (2017-2028) & (Units)
Figure 21. Asia-Pacific Antithrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Antithrombin Sales YoY (2017-2028) & (Units)
Figure 23. Latin America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Antithrombin Sales YoY (2017-2028) & (Units)
Figure 25. Middle East & Africa Antithrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Antithrombin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Antithrombin in the World: Market Share by Antithrombin Revenue in 2021
Figure 28. Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Antithrombin Sales Market Share by Type (2017-2028)
Figure 30. Global Antithrombin Revenue Market Share by Type (2017-2028)
Figure 31. Global Antithrombin Sales Market Share by Application (2017-2028)
Figure 32. Global Antithrombin Revenue Market Share by Application (2017-2028)
Figure 33. North America Antithrombin Sales Market Share by Type (2017-2028)
Figure 34. North America Antithrombin Revenue Market Share by Type (2017-2028)
Figure 35. North America Antithrombin Sales Market Share by Application (2017-2028)
Figure 36. North America Antithrombin Revenue Market Share by Application (2017-2028)
Figure 37. North America Antithrombin Sales Share by Country (2017-2028)
Figure 38. North America Antithrombin Revenue Share by Country (2017-2028)
Figure 39. U.S. Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Antithrombin Sales Market Share by Type (2017-2028)
Figure 42. Europe Antithrombin Revenue Market Share by Type (2017-2028)
Figure 43. Europe Antithrombin Sales Market Share by Application (2017-2028)
Figure 44. Europe Antithrombin Revenue Market Share by Application (2017-2028)
Figure 45. Europe Antithrombin Sales Share by Country (2017-2028)
Figure 46. Europe Antithrombin Revenue Share by Country (2017-2028)
Figure 47. Germany Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 48. France Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Antithrombin Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Antithrombin Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Antithrombin Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Antithrombin Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Antithrombin Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Antithrombin Revenue Share by Region (2017-2028)
Figure 58. China Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 61. India Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Antithrombin Sales Market Share by Type (2017-2028)
Figure 69. Latin America Antithrombin Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Antithrombin Sales Market Share by Application (2017-2028)
Figure 71. Latin America Antithrombin Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Antithrombin Sales Share by Country (2017-2028)
Figure 73. Latin America Antithrombin Revenue Share by Country (2017-2028)
Figure 74. Mexico Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Antithrombin Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Antithrombin Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Antithrombin Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Antithrombin Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Antithrombin Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Antithrombin Revenue Share by Country (2017-2028)
Figure 83. Turkey Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Antithrombin Revenue (2017-2028) & (US$ Million)
Figure 86. Antithrombin Value Chain
Figure 87. Antithrombin Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs